RU2612789C2 - Способ детектирования и характеризации токсиногенного штамма clostridium difficile - Google Patents
Способ детектирования и характеризации токсиногенного штамма clostridium difficile Download PDFInfo
- Publication number
- RU2612789C2 RU2612789C2 RU2011144853A RU2011144853A RU2612789C2 RU 2612789 C2 RU2612789 C2 RU 2612789C2 RU 2011144853 A RU2011144853 A RU 2011144853A RU 2011144853 A RU2011144853 A RU 2011144853A RU 2612789 C2 RU2612789 C2 RU 2612789C2
- Authority
- RU
- Russia
- Prior art keywords
- seq
- gene
- sample
- deletion
- deletions
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 47
- 241000193163 Clostridioides difficile Species 0.000 title claims abstract description 38
- 238000001514 detection method Methods 0.000 title claims abstract description 15
- 231100000033 toxigenic Toxicity 0.000 title claims abstract description 10
- 230000001551 toxigenic effect Effects 0.000 title claims abstract description 10
- 238000012512 characterization method Methods 0.000 title abstract description 3
- 238000012217 deletion Methods 0.000 claims abstract description 112
- 230000037430 deletion Effects 0.000 claims abstract description 112
- 239000002773 nucleotide Substances 0.000 claims abstract description 83
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 83
- 101150089436 tcdB gene Proteins 0.000 claims abstract description 29
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 26
- 101150032575 tcdA gene Proteins 0.000 claims abstract description 25
- 101150008941 cdtA gene Proteins 0.000 claims abstract description 19
- 239000003053 toxin Substances 0.000 claims abstract description 17
- 231100000765 toxin Toxicity 0.000 claims abstract description 17
- 238000011529 RT qPCR Methods 0.000 claims abstract description 11
- 101150108363 cdtB gene Proteins 0.000 claims abstract description 3
- 239000000523 sample Substances 0.000 claims description 126
- 230000003321 amplification Effects 0.000 claims description 41
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 41
- 238000006243 chemical reaction Methods 0.000 claims description 36
- 108091093088 Amplicon Proteins 0.000 claims description 19
- 239000003269 fluorescent indicator Substances 0.000 claims description 18
- 108700012359 toxins Proteins 0.000 claims description 18
- 230000003287 optical effect Effects 0.000 claims description 16
- 239000011541 reaction mixture Substances 0.000 claims description 14
- 238000007403 mPCR Methods 0.000 claims description 11
- 238000004458 analytical method Methods 0.000 claims description 9
- 101150076489 B gene Proteins 0.000 claims description 8
- 101710112752 Cytotoxin Proteins 0.000 claims description 8
- 231100000599 cytotoxic agent Toxicity 0.000 claims description 8
- 239000002619 cytotoxin Substances 0.000 claims description 8
- 241001465754 Metazoa Species 0.000 claims description 7
- 238000012544 monitoring process Methods 0.000 claims description 6
- 210000003608 fece Anatomy 0.000 claims description 4
- 101710146739 Enterotoxin Proteins 0.000 claims description 2
- 239000000147 enterotoxin Substances 0.000 claims description 2
- 231100000655 enterotoxin Toxicity 0.000 claims description 2
- 238000011156 evaluation Methods 0.000 claims 2
- 238000012360 testing method Methods 0.000 abstract description 11
- 239000000126 substance Substances 0.000 abstract description 7
- 238000012408 PCR amplification Methods 0.000 abstract 1
- 238000010222 PCR analysis Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 description 37
- 102000039446 nucleic acids Human genes 0.000 description 37
- 150000007523 nucleic acids Chemical class 0.000 description 37
- 238000003752 polymerase chain reaction Methods 0.000 description 27
- 239000012528 membrane Substances 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 14
- 238000003753 real-time PCR Methods 0.000 description 14
- 238000000605 extraction Methods 0.000 description 13
- 239000012530 fluid Substances 0.000 description 11
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 9
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 9
- 108020004414 DNA Proteins 0.000 description 8
- 230000009089 cytolysis Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 230000004888 barrier function Effects 0.000 description 7
- 230000036541 health Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 230000027455 binding Effects 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- 108090001007 Interleukin-8 Proteins 0.000 description 4
- 102100022389 Nucleosome assembly protein 1-like 1 Human genes 0.000 description 4
- 239000000356 contaminant Substances 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 230000009931 harmful effect Effects 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- -1 nucleoside triphosphates Chemical class 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 241000239226 Scorpiones Species 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 241000589596 Thermus Species 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000006037 cell lysis Effects 0.000 description 3
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000010612 desalination reaction Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 108091033319 polynucleotide Proteins 0.000 description 3
- 102000040430 polynucleotide Human genes 0.000 description 3
- 239000002157 polynucleotide Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- VGIRNWJSIRVFRT-UHFFFAOYSA-N 2',7'-difluorofluorescein Chemical compound OC(=O)C1=CC=CC=C1C1=C2C=C(F)C(=O)C=C2OC2=CC(O)=C(F)C=C21 VGIRNWJSIRVFRT-UHFFFAOYSA-N 0.000 description 2
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 2
- 239000012099 Alexa Fluor family Substances 0.000 description 2
- 241000304886 Bacilli Species 0.000 description 2
- 241000193403 Clostridium Species 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 2
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000011236 particulate material Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 2
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 101100519158 Arabidopsis thaliana PCR2 gene Proteins 0.000 description 1
- 206010009657 Clostridium difficile colitis Diseases 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010022004 Influenza like illness Diseases 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 description 1
- 102000029749 Microtubule Human genes 0.000 description 1
- 108091022875 Microtubule Proteins 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 101900232935 Pyrococcus furiosus DNA polymerase Proteins 0.000 description 1
- 101000902578 Pyrococcus woesei DNA polymerase Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 101710084578 Short neurotoxin 1 Proteins 0.000 description 1
- 241000205091 Sulfolobus solfataricus Species 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 241001235254 Thermococcus kodakarensis Species 0.000 description 1
- 241000204666 Thermotoga maritima Species 0.000 description 1
- 241000557720 Thermus brockianus Species 0.000 description 1
- 241000589498 Thermus filiformis Species 0.000 description 1
- 241000589499 Thermus thermophilus Species 0.000 description 1
- 108010085671 Thermus thermophilus DNA polymerase Proteins 0.000 description 1
- 108010001244 Tli polymerase Proteins 0.000 description 1
- 101710182223 Toxin B Proteins 0.000 description 1
- 101710182532 Toxin a Proteins 0.000 description 1
- 241000245032 Trillium Species 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241000282458 Ursus sp. Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000003196 chaotropic effect Effects 0.000 description 1
- 238000003508 chemical denaturation Methods 0.000 description 1
- 239000012501 chromatography medium Substances 0.000 description 1
- 229940088516 cipro Drugs 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000005447 environmental material Substances 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000013100 final test Methods 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 229940124307 fluoroquinolone Drugs 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000011491 glass wool Substances 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 229960003376 levofloxacin Drugs 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 210000004688 microtubule Anatomy 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 210000004910 pleural fluid Anatomy 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/143—Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/145—Clostridium
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09157547.2 | 2009-04-07 | ||
| EP09157547 | 2009-04-07 | ||
| PCT/IB2010/051396 WO2010116290A1 (en) | 2009-04-07 | 2010-03-31 | Method for the detection and characterization of a toxinogenic clostridium difficile strain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2011144853A RU2011144853A (ru) | 2013-05-20 |
| RU2612789C2 true RU2612789C2 (ru) | 2017-03-13 |
Family
ID=42224104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2011144853A RU2612789C2 (ru) | 2009-04-04 | 2010-03-31 | Способ детектирования и характеризации токсиногенного штамма clostridium difficile |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20120028819A1 (enExample) |
| EP (1) | EP2419527B1 (enExample) |
| JP (1) | JP5859424B2 (enExample) |
| KR (1) | KR101798211B1 (enExample) |
| CN (1) | CN102378817B (enExample) |
| BR (1) | BRPI1006757A2 (enExample) |
| RU (1) | RU2612789C2 (enExample) |
| WO (1) | WO2010116290A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2841390C1 (ru) * | 2024-11-27 | 2025-06-06 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный аграрный университет" (ФГБОУ ВО СПбГАУ) | Способ оценки генов токсинов Clostridium perfringens и Clostridioides difficile в консервированных объемистых кормах для крупного рогатого скота |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120028819A1 (en) | 2009-04-07 | 2012-02-02 | Koninklijke Philips Electronics N.V. | Method for the detection and characterization of a toxinogenic clostridium difficile strain |
| WO2012087135A1 (en) | 2010-12-22 | 2012-06-28 | Academisch Ziekenhuis Leiden H.O.D.N. Lumc | Genetic markers specific for clostridium difficile ribotypes 027 (nap01/b1; rt 027) and 078 (nap7/8; rt 078) and their use |
| GB201110712D0 (en) | 2011-06-23 | 2011-08-10 | Univ Ulster | Diagnostic methods |
| CN108866169A (zh) * | 2011-07-06 | 2018-11-23 | 探索诊断投资公司 | 病毒和细菌病原体的直接扩增和检测 |
| GB201207998D0 (en) * | 2012-05-08 | 2012-06-20 | Univ Cardiff | A screening method for the detection of clostridium difficle |
| US9133527B2 (en) * | 2012-05-11 | 2015-09-15 | Techlab, Inc. | Cell wall protein CwpV (CD0514) as a diagnostic marker for Clostridium difficile ribotype 027 |
| KR101955329B1 (ko) * | 2012-06-08 | 2019-03-07 | 삼성전자주식회사 | 클로스트리디움 디피실리 균주 검출용 조성물과 키트 및 이를 이용한 검출 방법 |
| CN102952886A (zh) * | 2012-11-28 | 2013-03-06 | 中华人民共和国张家港出入境检验检疫局 | 艰难梭菌肠毒素a、b双重荧光定量pcr检测方法及检测用试剂盒 |
| WO2014164563A1 (en) | 2013-03-13 | 2014-10-09 | Quidel Corporation | Pcr assays and reagents for molecular detection of infectious agents |
| TWI504751B (zh) * | 2013-09-25 | 2015-10-21 | Univ Nat Cheng Kung | 檢測困難梭狀桿菌核醣分型027之序列、技術平台及其方法 |
| FI126289B (en) * | 2014-12-19 | 2016-09-15 | Mobidiag Ltd | Method for detecting the presence of a hypervirulent strain of Clostridium difficile |
| US20190211377A1 (en) * | 2016-12-22 | 2019-07-11 | Roche Molecular Systems, Inc. | Cobra probes to detect a marker for epidemic ribotypes of clostridium difficile |
| JP2021506274A (ja) * | 2017-12-15 | 2021-02-22 | ジェン−プローブ・インコーポレーテッド | 毒素産生Clostridium difficileを検出するための組成物および方法 |
| EP3822370A1 (en) | 2019-11-15 | 2021-05-19 | Curiosity Diagnostics Sp. z o.o. | Method of determining the presence of a hyper-virulent clostridioides difficile strain of the b1/nap1/027 group in a sample |
| CN111705150B (zh) * | 2020-08-19 | 2020-12-25 | 中南大学湘雅医院 | 用于检测艰难梭菌核糖体027型毒力调节基因tcdC的方法、引物和试剂盒 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2348695C2 (ru) * | 2006-05-23 | 2009-03-10 | Закрытое акционерное общество "Молекулярно-медицинские технологии" | Дифференцирующий и специфический олигонуклеотиды для идентификации последовательностей днк инфекционных агентов в биологических материалах, способ видовой идентификации инфекционных агентов, биочип и набор для осуществления этого способа |
| WO2009030031A1 (en) * | 2007-09-06 | 2009-03-12 | Geneohm Sciences Canada, Inc. | Detection of toxigenic strains of clostridium difficile |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5298421A (en) | 1990-04-26 | 1994-03-29 | Calgene, Inc. | Plant medium-chain-preferring acyl-ACP thioesterases and related methods |
| US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| US5925517A (en) | 1993-11-12 | 1999-07-20 | The Public Health Research Institute Of The City Of New York, Inc. | Detectably labeled dual conformation oligonucleotide probes, assays and kits |
| WO1997046714A1 (en) | 1996-06-04 | 1997-12-11 | University Of Utah Research Foundation | Monitoring hybridization during pcr |
| FR2812306B1 (fr) * | 2000-07-28 | 2005-01-14 | Gabriel Festoc | Systeme d'amplification en chaine par polymerse de sequences nucleiques cibles |
| JP4999103B2 (ja) * | 2004-10-27 | 2012-08-15 | セフィード | 閉鎖系の多段階核酸増幅反応 |
| US20070026426A1 (en) * | 2005-04-26 | 2007-02-01 | Applera Corporation | System for genetic surveillance and analysis |
| JP5596893B2 (ja) * | 2006-11-10 | 2014-09-24 | キヤノン株式会社 | プローブセット、プローブ固定担体及び遺伝子検査方法 |
| US7687084B2 (en) | 2007-08-06 | 2010-03-30 | Tien Linsheng W | Cool-pet system |
| WO2009100215A2 (en) * | 2008-02-08 | 2009-08-13 | Mayo Foundation For Medical Education And Research | Detection of clostridium difficile |
| US20120028819A1 (en) | 2009-04-07 | 2012-02-02 | Koninklijke Philips Electronics N.V. | Method for the detection and characterization of a toxinogenic clostridium difficile strain |
-
2010
- 2010-03-31 US US13/262,844 patent/US20120028819A1/en not_active Abandoned
- 2010-03-31 JP JP2012504107A patent/JP5859424B2/ja active Active
- 2010-03-31 CN CN201080014449.3A patent/CN102378817B/zh active Active
- 2010-03-31 KR KR1020117026359A patent/KR101798211B1/ko active Active
- 2010-03-31 BR BRPI1006757-4A patent/BRPI1006757A2/pt not_active Application Discontinuation
- 2010-03-31 EP EP10713524.6A patent/EP2419527B1/en not_active Revoked
- 2010-03-31 WO PCT/IB2010/051396 patent/WO2010116290A1/en not_active Ceased
- 2010-03-31 RU RU2011144853A patent/RU2612789C2/ru active
-
2017
- 2017-06-08 US US15/617,010 patent/US10876174B2/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2348695C2 (ru) * | 2006-05-23 | 2009-03-10 | Закрытое акционерное общество "Молекулярно-медицинские технологии" | Дифференцирующий и специфический олигонуклеотиды для идентификации последовательностей днк инфекционных агентов в биологических материалах, способ видовой идентификации инфекционных агентов, биочип и набор для осуществления этого способа |
| WO2009030031A1 (en) * | 2007-09-06 | 2009-03-12 | Geneohm Sciences Canada, Inc. | Detection of toxigenic strains of clostridium difficile |
Non-Patent Citations (8)
| Title |
|---|
| BOUVET P.J. et al., Genetic relatedness of Clostridium difficile isolates from various origins determined by triple-locus sequence analysis based on toxin regulatory genes tcdC, tcdR, and cdtR, J Clin Microbiol. 2008, v.46, no.11, p. 3703-3713. * |
| CURRY S.R. et al., tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile, J Clin Microbiol, 2007, v.45, no.1, p. 215-221. * |
| MACCANNELL D.R. et al., Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada, J Clin Microbiol, 2006, v.44, no.6, p. 2147-2152. * |
| PERSSON S. et al., New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection, Clin Microbiol Infect, 2008, v.14, no.11, p.1057-1064. * |
| SPIGAGLIA P. et al., Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates, J Clin Microbiol, 2002, v.40, no.9, p. 3470-3475. * |
| SPIGAGLIA P. et al., Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates, J Clin Microbiol, 2002, v.40, no.9, p. 3470-3475. CURRY S.R. et al., tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile, J Clin Microbiol, 2007, v.45, no.1, p. 215-221. BOUVET P.J. et al., Genetic relatedness of Clostridium difficile isolates from various origins determined by triple-locus sequence analysis based on toxin regulatory genes tcdC, tcdR, and cdtR, J Clin Microbiol. 2008, v.46, no.11, p. 3703-3713. PERSSON S. et al., New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection, Clin Microbiol Infect, 2008, v.14, no.11, p.1057-1064. WOLFF D. et al., Rapid detection of the Clostridium difficile ribotype 0 * |
| VAN DEN BERG R.J. et al., Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping, J Clin Microbiol, 2004, v.42, no.3, p.1035-1041. * |
| WOLFF D. et al., Rapid detection of the Clostridium difficile ribotype 027 tcdC gene frame shift mutation at position 117 by real-time PCR and melt curve analysis, Eur J Clin Microbiol Infect Dis, 2009, v.28, no.8, p. 959-962. * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2841390C1 (ru) * | 2024-11-27 | 2025-06-06 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный аграрный университет" (ФГБОУ ВО СПбГАУ) | Способ оценки генов токсинов Clostridium perfringens и Clostridioides difficile в консервированных объемистых кормах для крупного рогатого скота |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20120005019A (ko) | 2012-01-13 |
| EP2419527B1 (en) | 2013-06-26 |
| US10876174B2 (en) | 2020-12-29 |
| CN102378817A (zh) | 2012-03-14 |
| CN102378817B (zh) | 2015-09-30 |
| KR101798211B1 (ko) | 2017-11-15 |
| US20120028819A1 (en) | 2012-02-02 |
| WO2010116290A1 (en) | 2010-10-14 |
| JP2012528567A (ja) | 2012-11-15 |
| US20180237827A1 (en) | 2018-08-23 |
| EP2419527A1 (en) | 2012-02-22 |
| BRPI1006757A2 (pt) | 2020-03-10 |
| RU2011144853A (ru) | 2013-05-20 |
| JP5859424B2 (ja) | 2016-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2612789C2 (ru) | Способ детектирования и характеризации токсиногенного штамма clostridium difficile | |
| EP3320110B1 (en) | 16s ribosomal rna universal primers and use thereof in microbiological analysis and diagnostics | |
| JP7055020B2 (ja) | 薬剤に対する生物の応答のマイクロ流体測定 | |
| EP2271767B1 (en) | Amplicon rescue multiplex polymerase chain reaction for amplificaton of multiple targets | |
| CA2840964C (en) | Direct amplification and detection of viral and bacterial pathogens | |
| TWI697560B (zh) | 用於偵測細菌污染之方法及組合物 | |
| CA2895945C (en) | Target capture system | |
| Amita et al. | Qualitative evaluation of mycobacterial DNA extraction protocols for polymerase chain reaction | |
| US8895240B2 (en) | Method, kit and system for collecting and processing samples for DNA and RNA detection | |
| BRPI0517131B1 (pt) | Métodos para simplificar ácidos nucléicos microbiais por modificação química de citosinas | |
| WO2009061752A1 (en) | Methods for detecting toxigenic microbes | |
| De Felice et al. | Latest trends in biosensors powered by nucleic acid isothermal amplification for the diagnosis of joint infections: From sampling to identification towards the point-of-care | |
| Hockman et al. | Comparison of multiplex PCR hybridization-based and singleplex real-time PCR-based assays for detection of low prevalence pathogens in spiked samples | |
| US20250290165A1 (en) | Viral variant detection | |
| EP1851325B1 (en) | Method for detecting viable cells in a sample by using a virus | |
| Mohammed et al. | Review on polymerase chain reaction and its diagnostic merit over conventional techniques in animal disease | |
| KR101911017B1 (ko) | 타일로렐라 에퀴제니탈리스의 검출용 조성물, 타일로렐라 에퀴제니탈리스 감염에 의한 말전염성자궁염의 진단용 조성물, 타일로렐라 에퀴제니탈리스의 검출방법, 및 타일로렐라 에퀴제니탈리스 감염에 의한 말전염성자궁염의 진단방법 | |
| RU2814556C1 (ru) | Тест-система для выявления ДНК возбудителя пастереллеза (Pasteurella multocida) в биологическом материале животных и кормах с помощью полимеразной цепной реакции в режиме реального времени | |
| TELLI | PRINCIPLES of POLYMERASE CHAIN REACTION TECHNOLOGY an d APPLICATIONS n THE FOOD SCIENCE | |
| WO2016209938A1 (en) | Compositions and methods for processing a biological sample | |
| Lindström et al. | Detection of Clostridium botulinum by multiplex PCR in foods and feces | |
| De Bruin et al. | Molecular detection and typing of Coxiella burnetii | |
| CN120752352A (zh) | 可存活细胞检测及其实施方案 | |
| EP3169796A1 (en) | Methods of detecting trichomonas vaginalis | |
| Kubo et al. | Hot cell-direct PCR aimed at specific cell detection |